The overexpression of miR‐194 inhibits targeted protein kinases to reduce α‐SMA and COL1 protein expressions, blocks cell cycle, and inhibits the activation and proliferation of HSCs, thereby alleviating liver fibrosis.12 This evidence concerns the gene ACTA1 and Hepatic fibrosis.